Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. shares experienced a significant increase in price, opening at $5.87 after closing at $4.90, indicating strong early trading momentum.
  • Analysts have set an average target price of $13.00 for Veradigm, with the overall rating being a "Hold," suggesting cautious sentiment among investors.
  • The stock has seen a 13.3% decline overall, with current moving averages standing at $4.75 for 50 days and $4.59 for 200 days, reflecting potential stability concerns.
  • Five stocks we like better than Veradigm.

Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $4.90, but opened at $5.87. Veradigm shares last traded at $5.87, with a volume of 524 shares traded.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen initiated coverage on shares of Veradigm in a research note on Tuesday, May 20th. They issued a "hold" rating on the stock. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $13.00.

Get Our Latest Stock Report on MDRX

Veradigm Stock Down 1.8%

The business's fifty day moving average is $4.77 and its two-hundred day moving average is $4.58.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.